Gabelli Healthcare & WellnessRx Trust (GRX) has a profit margin of 6.62%, below the sector sector average of 19.62%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
The latest profit margin for GRX is 6.62% as of December 2025. That compares with 213.9% in the prior-year period — down 96.9% year over year. That is below the sector sector average of 19.62%. Investors often review this figure alongside Gabelli Healthcare & WellnessRx Trust's historical trend and sector peers before judging valuation or financial health.
Over the past year, GRX's profit margin moved from 213.9% to 6.62% — a 96.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Gabelli Healthcare & WellnessRx Trust's valuation or profitability profile.
Against its sector companies, GRX currently prints 6.62% for profit margin, while the sector average sits near 19.62%. That is roughly 66.2% below the sector mean. Large gaps often invite a closer look at Gabelli Healthcare & WellnessRx Trust's growth, margins, and balance sheet.
Profit Margin shows how effectively Gabelli Healthcare & WellnessRx Trust converts resources into returns. At 6.62%, GRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 213.9% in the prior-year period — down 96.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GRX's profit margin (6.62%), review year-over-year change from 213.9%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.